clinical trial · NCT02153437
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
Bristol-Myers Squibb·phase1·terminated·n = 7
Atrial FibrillationBMS-919373SotalolPlacebo for BMS-919373
brief summary
To determine the effect of our compound (BMS-919373) on electrical activity of the heart using pacemakers.
started
Oct 30, 2014
primary completion
Oct 20, 2016
completion
Oct 20, 2016
last updated
Dec 19, 2023
official title
A Study of the Effects of BMS-919373 on Atrial Effective Refractory Period in Subjects With a Dual-Chamber Pacemaker
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol